Inactive Instrument
Pele Mountain Resources Inc. Stock Toronto S.E.
Stocks
GEM
CA7059071034
Pharmaceuticals
OTC Markets Traded| Market Cap | 4.17M 3.63M 3.44M 3.12M 5.83M 399M 5.86M 40.91M 15.82M 203M 15.65M 15.31M 649M | P/E 2020 |
-1.12x | P/E 2021 | -4.09x |
|---|---|---|---|---|---|
| Enterprise Value | 3.21M 2.8M 2.65M 2.41M 4.49M 308M 4.52M 31.53M 12.19M 156M 12.06M 11.8M 500M | EV / Sales 2020 |
3.39x | EV / Sales 2021 | 12.1x |
| Free-Float |
97.16% | Yield 2020 * |
-
| Yield 2021 | - |
| 1 day | -11.11% |
| Manager | Title | Age | Since |
|---|---|---|---|
John Simmonds
CEO | Chief Executive Officer | 50 | 10/08/2022 |
Ankit Gosain
DFI | Director of Finance/CFO | - | - |
Dina Qahwaji
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John Simmonds
CHM | Chairman | 50 | 28/01/2021 |
Paul Pellegrini
BRD | Director/Board Member | - | 26/10/2022 |
Stephen Gledhill
BRD | Director/Board Member | 64 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -11.11% | -11.11% | - | - | 264 | |
| +2.57% | +5.51% | +40.06% | -34.38% | 2.66B | |
| -0.89% | -0.12% | -15.81% | +131.53% | 589M | |
| +2.04% | 0.00% | -10.71% | -16.67% | 53.72M | |
| Average | -1.85% | -2.16% | +4.51% | +26.83% | 1.1B | |
| Weighted average by Cap. | +1.94% | -0.64% | +29.27% | -4.52% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | 1.63M 1.42M 1.34M 1.22M 2.28M 156M 2.29M 15.98M 6.18M 79.21M 6.11M 5.98M 254M | 1.27M 1.1M 1.04M 949K 1.77M 121M 1.78M 12.43M 4.81M 61.64M 4.76M 4.65M 197M |
| Net income | -4.42M -3.85M -3.64M -3.31M -6.18M -423M -6.21M -43.38M -16.77M -215M -16.6M -16.23M -688M | -3.3M -2.87M -2.72M -2.47M -4.61M -316M -4.64M -32.38M -12.52M -161M -12.39M -12.11M -514M |
| Net Debt | 140K 122K 115K 105K 196K 13.41M 197K 1.37M 531K 6.81M 526K 514K 21.81M | -956K -832K -788K -716K -1.34M -91.51M -1.34M -9.38M -3.63M -46.51M -3.59M -3.51M -149M |
Employees
-
Sector
Pharmaceuticals
